Events Partner Content Microbiome Drug Development Boston 2018 Pioneering The Microbiome Into Effective Medicines
Partner Content Partner Content Microbiome Drug Development Boston - Your Invite Pioneering The Microbiome Into Effective Medicines
Partner Content Partner Content 7th Annual HPAPI Summit - Boston 2018 Explore Unique Potent Compound Case Studies
Partner Content Partner Content How Will Spark’s Approval Impact the Gene Therapy Field? Gene Therapy for Rare Disorders Summit
Events Partner Content 3rd Annual Medical Device Project and Portfolio Management This two-day event guarantees top notch networking
News Aimmune to file peanut allergy treatment by year-end Backed by a $202 million fundraiser, biotech Aimmune has announced plans to file its potential peanut allergy treatment at the end of the year following a phase 3 trial success.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
